SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-026754
Filing Date
2023-02-28
Accepted
2023-02-28 16:30:20
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM OPPORTUNITIES II (GP), LLC5AM OPPORTUNITIES II, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABDR. KUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm238045d1_sc13da.htm SC 13D/A 147838
  Complete submission text file 0001104659-23-026754.txt   149570
Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93228 | Film No.: 23685989
SIC: 2834 Pharmaceutical Preparations